Compare SMSI & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMSI | ICU |
|---|---|---|
| Founded | 1982 | 2018 |
| Country | United States | United States |
| Employees | 118 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7M | 13.8M |
| IPO Year | 2017 | 2021 |
| Metric | SMSI | ICU |
|---|---|---|
| Price | $3.00 | $3.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.3K | ★ 70.1K |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,363,000.00 | $1,234,000.00 |
| Revenue This Year | $13.97 | $53.00 |
| Revenue Next Year | $53.35 | $50.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 814.07 |
| 52 Week Low | $0.41 | $0.22 |
| 52 Week High | $6.13 | $5.38 |
| Indicator | SMSI | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 60.73 | 42.71 |
| Support Level | $2.45 | $2.21 |
| Resistance Level | $3.19 | $4.96 |
| Average True Range (ATR) | 0.19 | 0.24 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 60.91 | 28.09 |
Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.